CompoAtlas

Leritone Genius 2- Leritone Études 2- Leritone cerveau 2- Leritone Santé cognitive 2- ABC 2- ADR 2- ADD

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Huile de poisson

Source : Anchois, sardines et maquereaux: Chair de poisson

Potency : 250 milligramme EPA

500 milligrammeNot calculated
Huile de poisson

Source : Anchois, sardines et maquereaux: Chair de poisson

Potency : 100 milligramme DHA

Not specifiedNot calculated
Oenothera biennis

Source : Graine(s)

Potency : 10 milligramme Acide gamma-linoléique(AGL)

100 milligrammeNot calculated
Lécithine de poisson

Source : Poissons pélagiques sauvages: Chair de poisson

Potency : 25 milligramme phospholipides de poisson

41.7 milligrammeNot calculated

Non-medicinal ingredients

Dioxyde de titane, Gélatine, Acétate de tocophérol, Ethyl Vanillin, Extrait de caroube, Glycérine

PopulationAgeQuantity per servingFrequency
Enfants (46-55kg)minimum: 8 years ; maximum: 15 years2 Capsule1 Tous les jours
Enfants (26-35kg)minimum: 8 years ; maximum: 15 years2 Capsule1 Tous les jours
Enfants (26-35kg)minimum: 8 years ; maximum: 15 years1 Capsule1 Tous les jours
Enfants (36-45kg)minimum: 8 years ; maximum: 15 years2 Capsule2 Tous les jours
Enfants (46-55kg)minimum: 8 years ; maximum: 15 years3 Capsule1 Tous les jours

Uses authorised in Canada

Améliore les niveaux de concentration chez les enfants de moins de 15 ans souffrant de trouble de l'attention avec ou sans hyperactivité. (TDA ou TDAH) Pourrait aider dans la prise en charge du TDA et du TDAH / May help in the management of ADD/ADHD. Aide à la concentration chez les enfants de moins de 15 ans souffrant de TDAH. Aide à contrôler les symptômes de TDA chez les enfants de 15 ans et moins. Supporte la santé cognitive et les fonctions cérébrales. Supporte le développement du cerveau, des yeux et des nerfs chez les enfants âgés de 12 ans et moins. Aide au développement du système nerveux.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Product record

Other names
Leritone TDAH-ADHD
Licence holder
IRB Yves Ponroy Canada Inc.
NPN or DIN-HM
80061868
Status
Active licence
Licence date
15 June 2015
Revision date
9 October 2015
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80061868

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Huile de poisson
    Read the warning, when it applies and the studies cited

    FISH OIL

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Pain of rheumatoid arthritis.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Condition of application: Healthy mood balance.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.

    Health Canada monograph dated 25 September 2026

  • Oenothera biennis
    Read the warning, when it applies and the studies cited

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Leritone Genius 2- Leritone Études 2- Leritone cerveau 2- Leritone Santé cognitive 2- ABC 2- ADR 2- ADD”, https://compoatlas.com/en/supplements/canada/80061868-leritone-genius-2-leritone-etudes-2-leritone-cerveau-2-lerit, updated 9 October 2015.

List recorded in 2015. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line